Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 7889

1.

Buccal Cytome Biomarkers and Their Association with Plasma Folate, Vitamin B<sub>12</sub> and Homocysteine in Alzheimer's Disease.

Thomas P, Fenech M.

J Nutrigenet Nutrigenomics. 2015 Jul 28;8(2):57-69. [Epub ahead of print]

PMID:
26228832
2.

Short-term white matter alterations in Alzheimer's disease characterized by diffusion tensor imaging.

Genc S, Steward CE, Malpas CB, Velakoulis D, O'Brien TJ, Desmond PM.

J Magn Reson Imaging. 2015 Jul 30. doi: 10.1002/jmri.25017. [Epub ahead of print]

PMID:
26228096
3.

Multi-stage Biomarker Models for Progression Estimation in Alzheimer's Disease.

Schmidt-Richberg A, Guerrero R, Ledig C, Molina-Abril H, Frangi AF, Rueckert D; Alzheimers Disease Neuroimaging Initiative.

Inf Process Med Imaging. 2015;24:387-98.

PMID:
26221689
4.

Alzheimer's disease cerebrospinal fluid biomarker in cognitively normal subjects.

Toledo JB, Zetterberg H, van Harten AC, Glodzik L, Martinez-Lage P, Bocchio-Chiavetto L, Rami L, Hansson O, Sperling R, Engelborghs S, Osorio RS, Vanderstichele H, Vandijck M, Hampel H, Teipl S, Moghekar A, Albert M, Hu WT, Monge Argilés JA, Gorostidi A, Teunissen CE, De Deyn PP, Hyman BT, Molinuevo JL, Frisoni GB, Linazasoro G, de Leon MJ, van der Flier WM, Scheltens P, Blennow K, Shaw LM, Trojanowski JQ; Alzheimer’s Disease Neuroimaging Initiative.

Brain. 2015 Jul 27. pii: awv199. [Epub ahead of print]

PMID:
26220940
5.

ADAM10 gene expression in the blood cells of Alzheimer's disease patients and mild cognitive impairment subjects.

Manzine PR, Marcello E, Borroni B, Kamphuis W, Hol E, Padovani A, Nascimento CC, de Godoy Bueno P, Assis Carvalho Vale F, Iost Pavarini SC, Di Luca M, Cominetti MR.

Biomarkers. 2015 Jul 29:1-6. [Epub ahead of print]

PMID:
26220620
6.

microRNA-Based Biomarkers and the Diagnosis of Alzheimer's Disease.

Zhao Y, Bhattacharjee S, Dua P, Alexandrov PN, Lukiw WJ.

Front Neurol. 2015 Jul 13;6:162. doi: 10.3389/fneur.2015.00162. eCollection 2015. Review. No abstract available.

7.

Chasing the Effects of Pre-Analytical Confounders - A Multicenter Study on CSF-AD Biomarkers.

Leitão MJ, Baldeiras I, Herukka SK, Pikkarainen M, Leinonen V, Simonsen AH, Perret-Liaudet A, Fourier A, Quadrio I, Veiga PM, de Oliveira CR.

Front Neurol. 2015 Jul 8;6:153. doi: 10.3389/fneur.2015.00153. eCollection 2015.

8.

Lipidomic analysis of p-chlorophenylalanine-treated mice using continuous-flow two-dimensional liquid chromatography/quadrupole time-of-flight mass spectrometry.

Weng R, Shen S, Yang L, Li M, Tian Y, Bai Y, Liu H.

Rapid Commun Mass Spectrom. 2015 Aug 30;29(16):1491-500. doi: 10.1002/rcm.7241.

PMID:
26212164
9.

A UHPLC-TOF/MS method based metabonomic study of total ginsenosides effects on Alzheimer disease mouse model.

Gong Y, Liu Y, Zhou L, Di X, Li W, Li Q, Bi K.

J Pharm Biomed Anal. 2015 Jul 16;115:174-182. doi: 10.1016/j.jpba.2015.07.007. [Epub ahead of print]

PMID:
26210744
10.

<sup>123</sup>I-MIBG myocardial scintigraphy and neurocirculatory abnormalities in patients with dementia with Lewy bodies and Alzheimer's disease.

Kim JS, Park HE, Oh YS, Song IU, Yang DW, Park JW, Lee KS.

J Neurol Sci. 2015 Jul 17. pii: S0022-510X(15)00446-3. doi: 10.1016/j.jns.2015.07.025. [Epub ahead of print]

PMID:
26208800
11.

Magneto-immunocapture with on-bead fluorescent labeling of amyloid-β peptides: towards a microfluidized-bed-based operation.

Mai TD, Pereiro I, Hiraoui M, Viovy JL, Descroix S, Taverna M, Smadja C.

Analyst. 2015 Jul 24. [Epub ahead of print]

PMID:
26206107
12.

Cognitive and Brain Profiles Associated with Current Neuroimaging Biomarkers of Preclinical Alzheimer's Disease.

Besson FL, La Joie R, Doeuvre L, Gaubert M, Mézenge F, Egret S, Landeau B, Barré L, Abbas A, Ibazizene M, de La Sayette V, Desgranges B, Eustache F, Chételat G.

J Neurosci. 2015 Jul 22;35(29):10402-11. doi: 10.1523/JNEUROSCI.0150-15.2015.

PMID:
26203136
13.

Integrated genomic approaches identify major pathways and upstream regulators in late onset Alzheimer's disease.

Li X, Long J, He T, Belshaw R, Scott J.

Sci Rep. 2015 Jul 23;5:12393. doi: 10.1038/srep12393.

14.

Oxidative Stress in Neurodegenerative Diseases.

Niedzielska E, Smaga I, Gawlik M, Moniczewski A, Stankowicz P, Pera J, Filip M.

Mol Neurobiol. 2015 Jul 22. [Epub ahead of print]

PMID:
26198567
15.

Big Biomedical data as the key resource for discovery science.

Toga AW, Foster I, Kesselman C, Madduri R, Chard K, Deutsch EW, Price ND, Glusman G, Heavner BD, Dinov ID, Ames J, Van Horn J, Kramer R, Hood L.

J Am Med Inform Assoc. 2015 Jul 21. pii: ocv077. doi: 10.1093/jamia/ocv077. [Epub ahead of print]

PMID:
26198305
16.

Impact of the Alzheimer's Disease Neuroimaging Initiative, 2004 to 2014.

Weiner MW, Veitch DP, Aisen PS, Beckett LA, Cairns NJ, Cedarbaum J, Donohue MC, Green RC, Harvey D, Jack CR Jr, Jagust W, Morris JC, Petersen RC, Saykin AJ, Shaw L, Thompson PM, Toga AW, Trojanowski JQ; Alzheimer's Disease Neuroimaging Initiative.

Alzheimers Dement. 2015 Jul;11(7):865-84. doi: 10.1016/j.jalz.2015.04.005. Review.

PMID:
26194320
17.

The Worldwide Alzheimer's Disease Neuroimaging Initiative: An update.

Hendrix JA, Finger B, Weiner MW, Frisoni GB, Iwatsubo T, Rowe CC, Kim SY, Guinjoan SM, Sevlever G, Carrillo MC.

Alzheimers Dement. 2015 Jul;11(7):850-9. doi: 10.1016/j.jalz.2015.05.008. Review.

PMID:
26194318
18.

Perspective: The Alzheimer's Disease Neuroimaging Initiative and the role and contributions of the Private Partner Scientific Board (PPSB).

Liu E, Luthman J, Cedarbaum JM, Schmidt ME, Cole PE, Hendrix J, Carrillo MC, Jones-Davis D, Tarver E, Novak G, De Santi S, Soares HD, Potter WZ, Siemers E, Schwarz AJ.

Alzheimers Dement. 2015 Jul;11(7):840-9. doi: 10.1016/j.jalz.2015.04.001. Review.

PMID:
26194317
19.

The Alzheimer's Disease Neuroimaging Initiative phase 2: Increasing the length, breadth, and depth of our understanding.

Beckett LA, Donohue MC, Wang C, Aisen P, Harvey DJ, Saito N; Alzheimer's Disease Neuroimaging Initiative.

Alzheimers Dement. 2015 Jul;11(7):823-31. doi: 10.1016/j.jalz.2015.05.004. Review.

PMID:
26194315
20.

Genetic studies of quantitative MCI and AD phenotypes in ADNI: Progress, opportunities, and plans.

Saykin AJ, Shen L, Yao X, Kim S, Nho K, Risacher SL, Ramanan VK, Foroud TM, Faber KM, Sarwar N, Munsie LM, Hu X, Soares HD, Potkin SG, Thompson PM, Kauwe JS, Kaddurah-Daouk R, Green RC, Toga AW, Weiner MW; Alzheimer's Disease Neuroimaging Initiative.

Alzheimers Dement. 2015 Jul;11(7):792-814. doi: 10.1016/j.jalz.2015.05.009. Review.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk